Explore other Johns Hopkins Sites
Wilmer Eye Institute at Johns Hopkins
 
 
 
 
Wilmer Eye Institute
 

David S. Friedman

David Steven Friedman, M.D., Ph.D., M.P.H.

David Steven Friedman, M.D., M.P.H.Assistant Professor

Wilmer Eye Institute
120 Wilmer
600 N. Wolfe Street
Baltimore, MD 21287

Education and Post-Graduate Training:

Wilmer Eye Institute, Baltimore, MD

Assistant Professor of Ophthalmology July 1996 - present Glaucoma Training Program (Harry Quigley, Henry Jampel, Alan Robin) July 1996 - June 1998

Johns Hopkins University, Baltimore, MD. Ph.D. in Epidemiology May 1997

Johns Hopkins University, Baltimore, MD. Masters of Public Health June 1997

Wills Eye Hospital, Philadelphia, PA. Resident Surgeon, Ophthalmology July 1993 - June 1996

New England Deaconess Hospital, Boston, MA. Medical Intern July 1992 - June 1993

Cicendo Eye Hospital, Bandung, Indonesia. Researcher on vitamin A deficiency working with Wilmer Eye Hospital and AID projects September 1990 - May 1991

Harvard Medical School, Boston, MA. Doctor of Medicine May 1992

Yale University, New Haven, CT. Bachelor of Arts in East Asian Studies May 1985

Taiwan National University, Taipei, Taiwan. Scholar in Chinese language September 1986 - June 1987

Beijing Teachers College, Beijing, China. Instructor in English January - June 1984

Middlebury Summer School, Middlebury, VT. Student of Chinese language June - August 1982 Honors and Awards:

Alpha Omega Delta Society (1996) Roy O. Scholz Award (1992) Paul Dudley White Scholarship Recipient (1990) Stanford University Scholarship Recipient (1987) Fulbright Scholarship Finalist (1987) Distinction in Major (1985) Phi Beta Kappa (1985) Summa cum laude Yale University (1985)

Publications:

Friedman DS, Duncan DD, Munoz B, West SK, Schein OD. A digital system for image capture and analysis of posterior capsule opacification. (Submitted to IOVS)

Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM. The prevalence of age-related macular degeneration among blacks and whites: The Baltimore Eye Survey. (Submitted to Ophthalmology)

Friedman DS, Schein OD. "Evidenced-Based Ophthalmic Surgery." In Evidence-Based Surgery. Cameron JL ed. Ontario: B.C. Decker, Inc. (Will be published 1999).

Friedman DS, Katz LJ, Augsburger JA, Lean M. Holmium laser sclerostomy in glaucomatous eyes with prior surgery: 24-month results. Ophthalmic Surg Lasers 1998;29:17-22.

Friedman DS, Schein, O. Assessing disability in the patient with cataract. Current Opinion in Ophthalmology 1998;9:1-4

Friedman DS, "Visual Fields" in Ophthalmology Secrets, Vander JF and Gault JA eds. Philadelphia: Hanley and Belfus, 1998

Friedman DS, Tielsch, JM. Epidemiologie des glaukoms. Search on Glaucoma 1997;5:28-30.

Friedman DS, Terebuh AK. Argyrosis in a patient with glaucoma. Ophthalmic Surgery 1995;26:274-275.

Humphrey JH, Natadisastra G, Muhilal, Friedman DS, Tielsch JM, West KP Jr, Sommer A. 210-mmol vitamin A provides more prolonged impact on vitamin A status than 105 mmol among preschool children. J Nutr 1994;124:1172-1178.

Agoestina T, Humphrey JH, Taylor GA, Usman A, Subardja D, Hidayat S, Nurachim, Wu L, Friedman DS, West KP Jr, Sommer A. Safety of one (52 mmol) 50,000 IU oral dose of vitamin A administered to neonates. Bull WHO 1994;72(6):859-868.

Agoestina T, Humphrey JH, Taylor GA, Usman A, Subardja D, Hidayat S, Nurachim, Wu L, Friedman DS, West KP Jr, Sommer A. Safety of one (52 mmol) 50,000 IU oral dose of vitamin A administered to neonates. FASEB Abstract, May 1994.

Congdon N, Sommer A, Severns M, Humphrey JH, Friedman DS, Clement LI, Wu L, Natadisastra G. Pupillary and visual thresholds in young children as an index of population vitamin A status. Am J Clin Nutr 1995;61(5):1076-1082.

PROFESSIONAL ACTIVITIES:

American Academy of Ophthalmology Member Refractive Errors Preferred Practice Patterns Panel Journal Reviews: American Journal of Ophthalmology Archives of Ophthalmology Association for Research in Vision and Ophthalmology (Member) American Academy of Ophthalmology (Member) Pennsylvania Ophthalmology Society (1993 - 1996)

LANGUAGES:

Fluent in Mandarin Proficient in Medical Spanish Conversant in Indonesian

> View Dr. Friedman's Complete CV

 
 
 
 
Controversy Swirls Around Lucentis

Julia Haller, professor of ophthalmology at Johns Hopkins explains why controversy swirls around Lucentis, a new drug approved by the FDA for the treatment of macular degeneration.

About John Hopkins - Find Out More

Out-of-State and International Patients - Find Out More

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

About Johns Hopkins Medicine | Patient Care | Education | Research | Health Information Library
Get Directions | Contact Us | Request an Appointment | Refer a Patient | Find a Doctor | Media Inquiries